Is this you?
Request access for Clinical Research Associates of Central PA with your @lunginnovations.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Clinical Research Associates of Central PA
Unclaimed profileIndependent Site · Altoona, Pennsylvania · ~1 sites
Intera lens
ICP 4Lift (cardio sample) 0.35Recruit soph 0
Quality Scorecard (1–100)
Overall85Recruit61Ops91Sponsor98Ther94
Performance (observed)
Historical trials
797
Completed
448
Terminated/Withdrawn
98
Completion rate
82%
Active now
231
Phase 2
201
Phase 3
535
Realized enrollment
777,979
First study year
1995
Years active
31
Match confidence
high
Enrollment velocity (inf)
25,096
Therapeutic
Areas
Pulmonology, Respiratory, COPD, Asthma, Bronchiectasis, Lung Cancer Screening, Cardiovascular
Specialties
Respiratory (COPD, asthma, bronchiectasis, diagnostic tools), cardiovascular, diabetic foot
Breadth (conditions)
1,151
States
Pennsylvania
Recruitment (web observed)
Capability notes
Moderate - focused pulmonology research with board-certified investigators
Relationships
Sponsors
Pfizer; Eli Lilly and Company; National Cancer Institute (NCI); AbbVie; Hoffmann-La Roche; SWOG Cancer Research Network
CROs
ICON Clinical Research; IQVIA Pty Ltd; IQVIA Pvt. Ltd; MacroGenics; Novotech (Australia) Pty Limited; PPD Development, LP
Partnerships
Part of Lung Innovations Network
Owner / parent
Private, Part of Lung Innovations Network
Expansion
State-of-the-art facility; 20+ years history
Capacity & people
Investigators
—
Coordinators
—
CEO
Sandeep Bansal, MD, FCCP, FACP (President & CEO)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
awitherow@lunginnovations.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
State-of-the-art research facility specializing in pulmonary/respiratory diseases. 11 employees, part of Lung Innovations Network. Part of UPMC Center of Excellence for Lung Cancer Screening and Lung Cancer Alliance Center of Excellence. ctgov_note: 7 recruiting trials across 1 location(s), states: Pennsylvania
Recommendation features (sample indication)
Ind fit 0.35Liftability 0.35Overall85
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.